Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H14N2OS |
| Molecular Weight | 222.307 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
SCCN1CC(NC1=O)C2=CC=CC=C2
InChI
InChIKey=KKEBXNMGHUCPEZ-UHFFFAOYSA-N
InChI=1S/C11H14N2OS/c14-11-12-10(8-13(11)6-7-15)9-4-2-1-3-5-9/h1-5,10,15H,6-8H2,(H,12,14)
| Molecular Formula | C11H14N2OS |
| Molecular Weight | 222.307 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:31:22 GMT 2023
by
admin
on
Sat Dec 16 10:31:22 GMT 2023
|
| Record UNII |
AC57BIX3H8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50954049
Created by
admin on Sat Dec 16 10:31:23 GMT 2023 , Edited by admin on Sat Dec 16 10:31:23 GMT 2023
|
PRIMARY | |||
|
135446
Created by
admin on Sat Dec 16 10:31:23 GMT 2023 , Edited by admin on Sat Dec 16 10:31:23 GMT 2023
|
PRIMARY | |||
|
32190-33-3
Created by
admin on Sat Dec 16 10:31:23 GMT 2023 , Edited by admin on Sat Dec 16 10:31:23 GMT 2023
|
PRIMARY | |||
|
AC57BIX3H8
Created by
admin on Sat Dec 16 10:31:23 GMT 2023 , Edited by admin on Sat Dec 16 10:31:23 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
The chromatogram obtained with solution (1) may show peaks due to the following impurities eluting at the following relative retention with reference to levamisole (retention time about 3.5 minutes): impurity C about 1.5.
In the chromatogram obtained with solution (1): ?the area of any peak corresponding to impurity C, when multiplied by a correction factor of 2.9, is not greater than 2 times the area of the peak due to levamisole in the chromatogram obtained with solution (4) (0.2%).
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity C by 2.9
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
